Vertex Pharmaceuticals Incorporated (VRTX) Gained 5.27% or 8.31 To Price $165.9 On Friday


Vertex Pharmaceuticals Incorporated (VRTX) gained 5.27% or 8.31 to $165.9. It is around 1.57 million shares traded, which is 77.36% compare to the average total volume 2.03 million. The market cap of VRTX is $42.12 billion. The year to date change is 3.06%. The 52 week price range is from $84.39 to $174.96. Price of VRTX have changed -2.08% during last week. It have changed -2.67% over last month, 7.17% over last 3 months, 1.36% over last 6 months and 83.69% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VRTX is 155.50. It is -6.27% below current price. The 200-day Moving Averages for VRTX is 145.77. It is -12.13% below current price. The 52-week High is 174.96. It is 5.46% from the current price. The 52-week Low is 84.39. It is -49.13% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of VRTX is 2.19 on 2018-01-31. Short % to float is 1.52%. There are some statistics of VRTX. It is has market cap $42.12 billion. The share outstanding is 253.89 million. The average volume is 2.03 million. The revenue is 2.49B. It has 4.89B cash and 1.70B in debt. The gross profit is 2.21B. The percent of top 15 Institution holding is 90.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VRTX is 15.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VRTX is 7.68%.


Tags:

Share this post